Ganeden Biotech is a biotechnology startup that specializes in creating a science-backed probiotic for foods and beverages. Their flagship product, BC30 (Bacillus coagulans GBI-30, 6086), is a patented, FDA GRAS probiotic ingredient found in over 900 leading food and beverage products worldwide. Unlike most probiotic strains, BC30 is a spore-former, which enhances its stability and viability during manufacturing processes and in the stomach's low pH acid. This strain has been extensively researched and demonstrated to promote digestive health, immune health, and protein utilization, supported by over 25 published papers.
Founded in 1997 and headquartered in the United States, Ganeden Biotech received a $12.00M Venture Round investment on 05 November 2007 from investors Capital Resource Partners and DSM Venturing. The company's focus on creating vegan, gluten-free, allergen-free, and non-GMO probiotic solutions has made them a key player in the biotechnology and manufacturing industries. Ganeden Biotech stands out for its innovative approach to functional food and beverages, paving the way for future growth opportunities in the sector.
